Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective

Author： Feng Ziding Prentice Ross Srivastava Sudir

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.6, 2004-09, pp. : 709-719

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Proteomic-Based Biomarker Discovery with Emphasis on Cerebrospinal Fluid and Multiple Sclerosis

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 3, 2006-06 ,pp. : 147-158

Bentham Science Publishers

Access to resources Recommend Favorite

SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics

By Simpkins Fiona Czechowicz Josephine A Liotta Lance Kohn Elise C

Pharmacogenomics, Vol. 6, Iss. 6, 2005-09 ,pp. : 647-653

Future Medicine

Access to resources Recommend Favorite

Proteomic Analysis of Liver Diseases: Molecular Mechanisms and Biomarker Discovery

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 1, 2008-01 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

Genomic & Proteomic Technological Advances in Cancer Research

By Khan Javed

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 245-249

Future Medicine

Access to resources Recommend Favorite

Genomic and Proteomic Techniques and their Application in Selenium Research

Current Pharmacogenomics, Vol. 1, Iss. 1, 2003-03 ,pp. : 59-65

Bentham Science Publishers

Access to resources Recommend Favorite